| Sarah Mccall, | |
|
5711 E 71st St Ste 100, Tulsa, OK 74136-6655 | |
| (918) 888-8080 | |
| Not Available |
| Full Name | Sarah Mccall |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 5711 E 71st St Ste 100, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043696990 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Mccall, 5224 E I 240 Service Rd Fl 2, Oklahoma City, OK 73135-2607 Ph: (405) 608-3800 | Sarah Mccall, 5711 E 71st St Ste 100, Tulsa, OK 74136-6655 Ph: (918) 888-8080 |
News Archive
A key to this "messaging" effort is highlighting the popular parts of the overhaul and connecting it to better economic conditions.
In recent years, advances in CT scanner technology have made perfusion computed tomography (CT) imaging an important diagnostic tool for patients with suspected stroke. Now, researchers at Mayo Clinic are working to reduce radiation dosages used to acquire perfusion and other CT images. Mayo Clinic medical physicist Cynthia McCollough, Ph.D., and her group of researchers presented their findings related to CT dose reduction at the 52nd Annual Meeting of the American Association of Physicists in Medicine on July 20 in Philadelphia.
Alexion Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental Biologics License Application (sBLA) providing regular approval for Soliris® (eculizumab) for the treatment of adult and pediatric patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy (TMA).
Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, has received clearance from the U.S. Food and Drug Administration (FDA) to market the IHC HER2 Breast Tissue Image Analysis application, available through its patented digital pathology platform.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
› Verified 4 days ago
Jennifer Christa Pimentel, ARNP, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6565 S Yale Ave Ste 209, Tulsa, OK 74136 Phone: 918-392-4550 Fax: 918-392-4551 | |
Casie Nicole Brim, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1919 S Wheeling Ave, Suite 606, Tulsa, OK 74104 Phone: 918-748-7676 Fax: 918-293-3130 | |
Jared Qualls, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Suite 460, Tulsa, OK 74104 Phone: 918-579-5749 Fax: 918-579-5762 | |
Adekemi Taiwo, APRN - CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Hillcrest South Medical Plaza, 8803 S. 101 St E. Ave. Suite 350, Tulsa, OK 74133 Phone: 918-615-3750 | |
Stephanie Ann Adame, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12697 E 51st St, Tulsa, OK 74146 Phone: 918-505-3200 | |
Mrs. Susan Elaine Graham, DNP, APRN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2408 E 81st St Ste 900, Tulsa, OK 74137 Phone: 918-319-5021 Fax: 918-477-5853 | |
Lisa Michele Sample, AG-ACNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6161 S Yale Ave, Tulsa, OK 74136 Phone: 918-494-2200 |